Completed PHASE3 INTERVENTIONAL 5-arm NCT01962298

Recovery of Diaphragmatic Function After Neuromuscular Blockade and Sugammadex (SUDIA)

Sugammadex and the Diaphragm: Recovery of Diaphragmatic Function and Neuromuscular Blockade. A Double-blind Randomized Controlled Trial

Sponsor: University Hospital, Antwerp

Conditions Diaphragmatic Dysfunction Muscle Fatigue Muscle Weakness

Interventions Continuous rocuronium infusion Repeated rocuronium dose Single rocuronium dose neostigmine placebo sugammadex 2mg/kg sugammadex 4mg/kg

Updated 6 times since 2017 Last updated: Mar 21, 2018 Started: Oct 31, 2013 Primary completion: Dec 31, 2014 Completion: Dec 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Diaphragmatic Dysfunction and Muscle Fatigue, this trial is completed. The trial is conducted by University Hospital, Antwerp and has accumulated 6 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Nov 2018 — Jan 2021 [monthly]

Completed PHASE3
Jun 2018 — Nov 2018 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Oct 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Antwerp

Data source: University Hospital, Antwerp

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Edegem, Belgium